(Q39257141)

English

Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 September 2017

Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana (English)

1 reference

Europe PubMed Central

10 September 2017

0 references

Plasmodium falciparum

0 references

0 references

0 references

Frank P Mockenhaupt

object named as

Frank P Mockenhaupt

1

0 references

Robert W Sauerwein

8

object named as

Robert W Sauerwein

1 reference

Europe PubMed Central

10 September 2017

author name string

J Teun Bousema

2

1 reference

Europe PubMed Central

10 September 2017

Teunis A Eggelte

3

1 reference

Europe PubMed Central

10 September 2017

Jonas Schreiber

4

1 reference

Europe PubMed Central

10 September 2017

Stephan Ehrhardt

5

1 reference

Europe PubMed Central

10 September 2017

Nasstasja Wassilew

6

1 reference

Europe PubMed Central

10 September 2017

Rowland N Otchwemah

7

1 reference

Europe PubMed Central

10 September 2017

Ulrich Bienzle

9

1 reference

Europe PubMed Central

10 September 2017

publication date

1 September 2005

1 reference

Europe PubMed Central

10 September 2017

Tropical Medicine and International Health

1 reference

Europe PubMed Central

10 September 2017

10

1 reference

Europe PubMed Central

10 September 2017

9

1 reference

Europe PubMed Central

10 September 2017

901-908

1 reference

Europe PubMed Central

10 September 2017

DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Treatment failure of pyrimethamine‐sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

The efficacy of antimalarial monotherapies, sulphadoxine–pyrimethamine and amodiaquine in East Africa: implications for sub‐regional policy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Efficacy of chloroquine in the treatment of uncomplicated, Plasmodium falciparum malaria in northern Ghana

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Risk factors of chloroquine resistance in Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Genetic markers of resistance to pyrimethamine and sulfonamides in Plasmodium falciparum parasites compared with the resistance patterns in isolates of Escherichia coli from the same children in Guinea-Bissau

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Detection of Plasmodium falciparum gametocytes with the OBC test and Giemsa-stained thick blood films for malaria transmission studies in Cameroon.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Ghana battles drug-resistant malaria with artesunate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

More on 'the efficacy of antifolate antimalarial combinations in Africa'.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Molecular markers for drug resistance in malaria: use in treatment, diagnosis and epidemiology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Field evaluation of the use of an ELISA to detect chloroquine and its metabolites in blood, urine and breast-milk

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Epidemiology of drug-resistant malaria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Changes in Plasmodium falciparum gametocytaemia in children with chloroquine-sensitive asexual infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon Region of Brazil

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2005.01471.X

21 January 2018

Identifiers

10.1111/J.1365-3156.2005.01471.X

1 reference

Europe PubMed Central

10 September 2017

1 reference

Europe PubMed Central

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39257141&oldid=1816070097"